Erratum to: Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties (AAPS PharmSciTech DOI: 10.1208/s12249-013-0070-y);Evaluation of Tadalafil nanosuspensions and their peg solid dispersion matrices for enhancing its dissolution properties

AAPS PharmSciTech

Volumn 15, Issue 2, 2014, Pages 364-374

  Obeidat, Wasfy M ^a   Sallam, Al Sayed A ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b TQ Pharma   (Jordan)

Author keywords

nanosuspension; particle size; solid dispersion; stabilizer; tablets; Tadalafil

Indexed keywords

MACROGOL 4000; NANOPARTICLE; NANOSUSPENSION; POLYSORBATE 80; SORBITAN OLEATE; STABILIZING AGENT; TADALAFIL; UNCLASSIFIED DRUG; CARBOLINE DERIVATIVE; MACROGOL DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR;

ADSORPTION; ALKALINITY; ARTICLE; COMPRESSION; CONFORMATION; CRUSHING STRENGTH; CRYSTALLIZATION; DIPOLE; DISPERSION; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; HYDROPHOBICITY; PARTICLE SIZE; POWDER; PRECIPITATION; PRIORITY JOURNAL; STEREOSPECIFICITY; SUSPENSION; TABLET FORMULATION; THERMOGRAPHY; ULTRASOUND; WEIGHT; ZETA POTENTIAL; CHEMISTRY; DRUG SCREENING; NANOTECHNOLOGY; SOLUBILITY;

CARBOLINES; DRUG EVALUATION, PRECLINICAL; NANOTECHNOLOGY; PARTICLE SIZE; PHOSPHODIESTERASE 5 INHIBITORS; POLYETHYLENE GLYCOLS; SOLUBILITY;

EID: 84898026386     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-014-0116-9     Document Type: Erratum

References (38)

1. Lomabardino JG, Lowe III JA. A guide to drug discovery: the role of the medicinal chemist in drug discovery - then and now. Nat Rev Drug Discov. 2004;3:853-62.
2. Thomas R. Solubility enhancement with BASF pharma polymers. Lampertheim: BASF SE Pharma Ingredients & Services; 2011.
3. Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62:3-16.
4. Lipinski C. Poor aqueous solubility - an industry wide problem in drug discovery. Am Pharm Rev. 2002;5:82-5.
5. Patro S, Himasankar K, Choudhury AA, Rao MEB. Effect of some hydrophilic polymers on dissolution rate of roxitromycin. Indian J Pharm Sci. 2005;67:334-41.
6. Omaima AS, Mohammed AH, Nagia AM, Ahmed SZ. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersions. AAPS PharmSciTech. 2006;2:1-9.
7. Trivedi JS, Wells ML. In: Liu R, editor. Solubilization using cosolvent approach. Water-insoluble drug formulation. Denver: Interpharm; 2000. p. 141-68.
8. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics, 4 ed. Hyderabad: Pharma Book Syndicate; 2008. p. 48.
9. Dressmann JB, Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci. 2000;1:73-80.
10. Keck C, Fichtinger A, Viernstein H, Müller RH. Oral drug nanocrystals - effect of potential aggregation on bioavailability. Abstract, AAPS Annual Meeting, Baltimore; 2004.
11. Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56:827-40.
12. Wong M, Kellaway IW, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm. 2006;317:61-8.
13. Xia D, Quan P, Cui F. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci. 2010;40:325-34.
14. Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, et al. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation- ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech. 2012;13:295-304.
15. Quan P, Xia D, Piao H, Piao H, Shi K, Jia Y, Cui F. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation. AAPS PharmSciTech. 2011;12:1136-43.
16. List M, Sucker H. Hydrosols of pharmacologically active agents and their pharmaceutical compositions comprising them. US5389382; 1995
17. Guo Z, Zhang M, Li H, Wang E, Kougouslos E. Effect of ultrasound on antisolvent crystallization process. J Cryst Growth. 2005;273:555-63.
18. Louhi-Kultanen M, Karjalainen M, Rananen J, Huhtanen M, Kallas J. Crystallization of glycine with ultrasound. Int J Pharm. 2006;320:23-9.
19. Verma S, Gokhaleb R, Burgessa DJ. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 2009;380:216-22.
20. Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3:785-96.
21. Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 h after dosing: a randomized controlled trial. Urology. 2003;62:121-6.
22. Anderson NR, Gullapalli RP. beta-Carboline pharmaceutical compositions. US6841167, 2001.
23. Hiemenz PC, Rajagopalan R. Principles of colloid and surface chemistry, 3rd ed. New York: Marcel-Dekker; 1997.
24. Caballero FG, Duran JGL. Suspension formulation. In: Nielloud F, editor. Pharmaceutical emulsions and suspensions. New York: Marcel Dekker; 2000. p. 127.
25. Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm. 2006;312:179-86.
26. Merck index 2006, 14th ed. p. 1550-1.
27. Napper DH. Steric stabilization and the Hofmeister series. J Colloid Interface Sci. 1970;33:384-92.
28. Smitham JB, Napper DH. Steric stabilization in worse than θ-solvents. Coll Polym Sci. 1979;257:748-56.
29. Rosen MJ. Surfactants and interfacial phenomena. New York: Wiley; 1989. p. 337.
30. ACD/PhysChem Suite. http://www.acdlabs.com/products/pc-admet/physchem/ physchemsuite. 2012.
31. Lee RW, Shaw JM, McShane J, Wood RW. In: Liu R, editor. Particle size reduction. Water-insoluble drug formulation. Denver: Interpharm; 2000.
32. Liu R, Sadrzadeh N, Constantinides PP. In: Liu R, editor. Micellization and drug solubility enhancement. Water-insoluble drug formulation. Denver: Interpharm; 2000. p. 213-354.
33. Xu Q, Vasudevan TV, Somasundaran PJ. Adsorption of anionic-nonionic and cationic-nonionic surfactant mixtures on kaolinite. Colloid Interface Sci. 1991;142:528-34.
34. Dongmei L, David GR. Mixed composition films of spans and Tween 80 at the air-water interface. Langmuir. 2000;16:8107-12.
35. Byron JP. Mixed surfactant systems to control dispersion stability in severe environments for enhancing chemical mechanical polishing (CMP) of metal surfaces. Ph.D. thesis, 2000.
36. Vyas V, Sancheti P, Karekar P. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Acta Pharm. 2009;59:453-61.
37. Ravi Kumar V, Sevukarajan M, Jayasri V, Pavankumar AG, Deepthi Y, Manjunath M, et al. Improvement of dissolution characteristics and bioavailability of tadalafil by solid dispersion technique using water-soluble polymers. Int J Adv Pharm. 2012;2(2):56-63.
38. Shaimaa MB-E, Seham AE, Mahmoud MG. Inclusion complexes of tadalafil with natural and chemically modified b-cyclodextrins. I: Preparation and in-vitro evaluation. Eur J Pharm Biopharm. 2008;70:819-27.